biote Corp. (BTMD)
USD 4.17
(4.13%)
USD 4.17
(4.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 155.29 Million USD | 39.1% |
| 2022 | 111.64 Million USD | 105.49% |
| 2021 | 54.33 Million USD | 66.72% |
| 2020 | 32.58 Million USD | 36.4% |
| 2019 | 23.89 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 160.1 Million USD | 3.1% |
| 2024 Q2 | 92.9 Million USD | -41.98% |
| 2023 FY | 155.29 Million USD | 39.1% |
| 2023 Q4 | 155.29 Million USD | 3.7% |
| 2023 Q3 | 149.74 Million USD | 7.69% |
| 2023 Q1 | 119.13 Million USD | 6.71% |
| 2023 Q2 | 139.05 Million USD | 16.72% |
| 2022 Q1 | 59.42 Million USD | 9.37% |
| 2022 FY | 111.64 Million USD | 105.49% |
| 2022 Q3 | 109.57 Million USD | -4.98% |
| 2022 Q2 | 115.32 Million USD | 94.08% |
| 2022 Q4 | 111.64 Million USD | 1.89% |
| 2021 Q1 | 319.01 Million USD | 878.96% |
| 2021 FY | 54.33 Million USD | 66.72% |
| 2021 Q4 | 54.33 Million USD | 13.31% |
| 2021 Q3 | 47.94 Million USD | -84.94% |
| 2021 Q2 | 318.44 Million USD | -0.18% |
| 2020 FY | 32.58 Million USD | 36.4% |
| 2020 Q4 | 32.58 Million USD | 0.0% |
| 2019 FY | 23.89 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 97.102% |
| Addus HomeCare Corporation | 1.02 Billion USD | 84.841% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | 27.28% |
| Amedisys, Inc. | 2.06 Billion USD | 92.462% |
| American Oncology Network, Inc. | 374.45 Million USD | 58.528% |
| Astrana Health, Inc. | 933.36 Million USD | 83.362% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 90.514% |
| IMAC Holdings, Inc. | 1.14 Million USD | -13473.326% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -153.664% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 77.14% |
| COMPASS Pathways plc | 275.98 Million USD | 43.731% |
| DocGo Inc. | 490.45 Million USD | 68.336% |
| The Ensign Group, Inc. | 4.17 Billion USD | 96.283% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 80.665% |
| InnovAge Holding Corp. | 547.66 Million USD | 71.644% |
| Assure Holdings Corp. | 7.51 Million USD | -1966.742% |
| The Joint Corp. | 87.15 Million USD | -78.191% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 93.046% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -1853.245% |
| ModivCare Inc. | 1.76 Billion USD | 91.213% |
| NewGenIvf Group Limited | 1.64 Million USD | -9326.329% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -336.675% |
| Option Care Health, Inc. | 3.32 Billion USD | 95.334% |
| P3 Health Partners Inc. | 860.96 Million USD | 81.963% |
| P3 Health Partners Inc. | 860.96 Million USD | 81.963% |
| The Pennant Group, Inc. | 539.69 Million USD | 71.225% |
| Surgery Partners, Inc. | 7.01 Billion USD | 97.788% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -3054.298% |
| Talkspace, Inc. | 142.22 Million USD | -9.193% |
| Talkspace, Inc. | 142.22 Million USD | -9.193% |
| The Oncology Institute, Inc. | 219.41 Million USD | 29.224% |
| The Oncology Institute, Inc. | 219.41 Million USD | 29.224% |